Jul 27, 2021 · Here, we describe two cases of safe, effective sublingual birch pollen AIT in HIV-positive patients undergoing concomitant antiretroviral therapy.

May 1, 1997 · Therapeutic interventions for allergic diseases in HIV-positive patients are usually no different from any other patient population.

HIV infection is a relative contraindication for allergic immunotherapy (AIT). In the last decade, highly active antiretroviral therapy (HAART) has improved the immune function and life …

Few articles in the published literature have explored whether allergen immunotherapy can be safely tolerated in HIV-infected patients undergoing stable HAART. We describe the effects of …

Dec 11, 2014 · It was highlighted that HIV infection altered the immune system causing cell-mediated immune deficiency and that the resulting immune dysfunction was the cause for the …

Jul 10, 2001 · Hypersensitivity problems are a significant issue for many persons with HIV infection before immunodeficiency is clinically evident.

Apr 24, 2025 · Allergy immunotherapy exposes your body to small amounts of allergens that increase gradually. This reduces your immune system’s sensitivity to the allergen and makes …

Mar 31, 2016 · Actually, HIV-infected patients, undergoing HAART, are particularly susceptible to atopic predispositions and chronic allergy and, moreover, subjects immunization may enhance …

Oct 3, 2006 · Allergen immunotherapy is a major therapeutic modality in the treatment of allergic rhinitis. However, with T-cell activation potential, its role in patients with human …

Allergen-specific immunotherapy (AIT) is a safe, effective treatment for respiratory allergies (such as moderate-to-severe allergic rhinoconjunctivitis) that are not controlled by symptomatic …